ILMN

Illumina, Inc. ILMN

$186.65 -3.60 (-1.89%)

Neutral · +0.68σ

+ Compare Open in Sniper

Price chart

Timeframe

Range

Loading…

Latest bar · ILMN

Momentum reads · latest daily bar

Last

$186.65

-3.60 (-1.89%)

Mkt cap

$28.2B

Healthcare

RSI(14)

58.3

neutral

Stochastic %K

62.1

neutral

MFI(14)

62.7

neutral

ADX(14)

39.0

trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

Quarter	Revenue	Net income	Op income	FCF	Net margin	Op margin
2026-03-31	$1.1B	$0.1B	$0.2B	$0.3B	12.3%	19.2%
2025-12-31	$1.2B	$0.3B	$0.2B	$0.3B	28.8%	18.2%
2025-09-30	$1.1B	$0.1B	$0.2B	$0.3B	13.8%	20.9%
2025-06-30	$1.1B	$0.2B	$0.2B	$0.2B	22.2%	20.2%
2025-03-31	$1.0B	$0.1B	$0.2B	$0.2B	12.6%	15.8%
2024-12-31	$nanB	$nanB	$nanB	$nanB	nan%	nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare ILMN vs peers

Line ILMN up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing ILMN MSFT× AMZN× META×

Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE

Popular + AAPL + NVDA + GOOG + TSLA + AVGO

Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Verdict

Weighted score 0-100 across 4 tickers · best in green

ILMN

score 56.7

5/5 inputs

Momentum score of 100 dominates with 40.63% three-month gain, offsetting weak quality and sentiment categories.

value 50growth 50quality 42momentum 100sentiment 36

MSFT

score 49.6

3/5 inputs

Perfect sentiment score of 100 and 20% insider buying lift total despite catastrophic zero momentum ranking.

quality 65momentum 0sentiment 100

AMZN

score 31.3

3/5 inputs

Weak sentiment score of 8 with negative 24% insider selling anchors this ticker to last place.

quality 51momentum 34sentiment 8

META

score 43.1

3/5 inputs

Quality score of 100 carries the ranking but zero sentiment and negative 28% insider selling drag performance.

quality 100momentum 33sentiment 0

Metric	ILMN Illumina, Inc.	MSFT MSFT	AMZN AMZN	META META
Snapshot
Price	186.65	393.82	247.23	646.01
Day %↕	-1.89	-1.82	-1.06	-2.79
1M %↕	13.62	-0.0	0.5	7.63
3M %↕	40.63	-6.29	-0.99	-4.56
YTD %↕	38.93	-16.73	9.15	-0.68
Market cap	28240144384.0	—	—	—
ADV ($)	345977041.786438	—	—	—
Beta	1.469	—	—	—
OdysseyHQ zone
Current zone	Neutral	Neutral	Neutral	Neutral
Dist 21-EMA %	2.54	1.16	0.6	3.85
Dist ATR (σ)	0.68	0.37	0.19	0.91
OdysseyHQ grade	—	—	—	C
Confluence↕	1	0	1	5
Valuation
P/E (ttm)↕	33.87477	—	—	—
P/E (fwd)↕	31.459738	—	—	—
P/S↕	6.428442	—	—	—
EV/EBITDA↕	25.653	—	—	—
P/B↕	10.602101	—	—	—
FCF yield↕	0.0299	—	—	—
PEG↕	3.32	—	—	—
Growth
Revenue yoy↕	0.048	—	—	—
EPS yoy↕	0.061	—	—	—
FCF yoy↕	—	—	—	—
Revenue trend 8Q
Quality
Gross margin↕	0.6829	—	—	—
Operating margin↕	0.18332	—	—	—
Net margin↕	0.19417	—	—	—
ROE↕	0.33822	—	—	—
ROA↕	0.08683	—	—	—
Debt / Equity↕	0.95	—	—	—
Interest cov.↕	11.75	52.84	43.79	74.76
Technicals
RSI(14)	58.3	51.9	51.3	56.8
MACD signal	neutral	neutral	bull	bull
vs 50-DMA	13.12	-1.92	-1.94	6.86
vs 200-DMA	38.41	-10.36	5.63	0.86
vs 52w high	-5.09	-29.1	-11.25	-18.87
HV-30	40.8	34.3	32.8	52.2
Sentiment
Analyst rec↕	2.35	—	—	—
Target upside↕	-10.19	—	—	—
Insider buy-sell 90d↕	-24	20	-24	-28
Risk
Short interest↕	8.17	—	—	—
Days to cover↕	3.64	—	—	—
Next earnings	2026-07-30	—	—	—

ILMN

Illumina, Inc.

$186.65

-1.89%

Snapshot

Price 186.65

Day % -1.89

1M % 13.62

3M % 40.63

YTD % 38.93

Market cap 28240144384.0

ADV ($) 345977041.786438

Beta 1.469

OdysseyHQ zone

Current zone Neutral

Dist 21-EMA % 2.54

Dist ATR (σ) 0.68

OdysseyHQ grade —

Confluence 1

Valuation

P/E (ttm) 33.87477

P/E (fwd) 31.459738

P/S 6.428442

EV/EBITDA 25.653

P/B 10.602101

FCF yield 0.0299

PEG 3.32

Growth

Revenue yoy 0.048

EPS yoy 0.061

FCF yoy —

Revenue trend 8Q

Quality

Gross margin 0.6829

Operating margin 0.18332

Net margin 0.19417

ROE 0.33822

ROA 0.08683

Debt / Equity 0.95

Interest cov. 11.75

Technicals

RSI(14) 58.3

MACD signal neutral

vs 50-DMA 13.12

vs 200-DMA 38.41

vs 52w high -5.09

HV-30 40.8

Sentiment

Analyst rec 2.35

Target upside -10.19

Insider buy-sell 90d -24

Risk

Short interest 8.17

Days to cover 3.64

Next earnings 2026-07-30

Full ILMN dashboard →

MSFT

$393.82

-1.82%

Snapshot

Price 393.82

Day % -1.82

1M % -0.0

3M % -6.29

YTD % -16.73

Market cap —

ADV ($) —

Beta —

OdysseyHQ zone

Current zone Neutral

Dist 21-EMA % 1.16

Dist ATR (σ) 0.37

OdysseyHQ grade —

Confluence 0

Valuation

P/E (ttm) —

P/E (fwd) —

P/S —

EV/EBITDA —

P/B —

FCF yield —

PEG —

Growth

Revenue yoy —

EPS yoy —

FCF yoy —

Revenue trend 8Q

Quality

Gross margin —

Operating margin —

Net margin —

ROE —

ROA —

Debt / Equity —

Interest cov. 52.84

Technicals

RSI(14) 51.9

MACD signal neutral

vs 50-DMA -1.92

vs 200-DMA -10.36

vs 52w high -29.1

HV-30 34.3

Sentiment

Analyst rec —

Target upside —

Insider buy-sell 90d 20

Risk

Short interest —

Days to cover —

Next earnings —

Full MSFT dashboard →

AMZN

$247.23

-1.06%

Snapshot

Price 247.23

Day % -1.06

1M % 0.5

3M % -0.99

YTD % 9.15

Market cap —

ADV ($) —

Beta —

OdysseyHQ zone

Current zone Neutral

Dist 21-EMA % 0.6

Dist ATR (σ) 0.19

OdysseyHQ grade —

Confluence 1

Valuation

P/E (ttm) —

P/E (fwd) —

P/S —

EV/EBITDA —

P/B —

FCF yield —

PEG —

Growth

Revenue yoy —

EPS yoy —

FCF yoy —

Revenue trend 8Q

Quality

Gross margin —

Operating margin —

Net margin —

ROE —

ROA —

Debt / Equity —

Interest cov. 43.79

Technicals

RSI(14) 51.3

MACD signal bull

vs 50-DMA -1.94

vs 200-DMA 5.63

vs 52w high -11.25

HV-30 32.8

Sentiment

Analyst rec —

Target upside —

Insider buy-sell 90d -24

Risk

Short interest —

Days to cover —

Next earnings —

Full AMZN dashboard →

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

Date	EPS actual	EPS est	Surprise	Next-day
2026-04-30	1.15	1.06	+9.0%	+7.1%
2026-02-05	1.35	1.23	+9.7%	-10.4%
2025-10-30	1.34	1.17	+14.7%	+24.8%
2025-07-31	1.19	1.01	+17.7%	-7.8%
2025-05-08	0.97	0.94	+3.3%	-4.8%
2025-02-06	0.86	0.92	-6.8%	-9.6%
2024-11-04	1.14	0.88	+29.0%	+1.0%
2024-08-06	0.36	0.90	-60.0%	+4.1%
2024-05-02	0.09	0.11	-15.1%	-4.9%
2024-02-08	0.14	0.12	+17.6%	-3.8%
2023-11-09	0.33	0.14	+135.1%	-8.1%
2023-08-09	0.32	0.02	+1326.0%	+0.3%
2023-04-25	0.08	0.03	+198.2%	-3.5%
2023-02-07	0.14	0.19	-24.8%	-8.0%
2022-11-03	0.34	0.30	+13.2%	+5.9%
2022-08-11	0.57	0.64	-11.6%	-8.4%
2022-05-05	1.07	0.89	+20.8%	-14.6%
2022-02-10	0.75	0.49	+54.5%	-7.6%
2021-11-04	1.45	1.22	+19.1%	-3.2%
2021-08-05	1.87	1.36	+37.1%	-3.6%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅	Mkt cap ⇅	P/E ⇅	Fwd P/E ⇅	P/S ⇅	EV/EBITDA ⇅	P/B ⇅	Gross M ⇅	Rev gr ⇅	EPS gr ⇅	FCF yld ⇅
ILMN ★	$28B	33.9	31.5	6.4	25.7	10.6	68.3%	4.8%	6.1%	2.99%
LLY	$1,051B	41.8	26.3	14.6	30.1	33.8	82.8%	55.5%	169.9%	0.87%
UNH	$387B	32.1	19.2	0.9	17.7	4.0	19.5%	0.4%	61.5%	5.88%
JNJ	$609B	29.3	19.7	6.2	18.4	7.5	68.1%	6.6%	-1.0%	—
MRK	$315B	36.0	13.2	4.8	12.1	6.9	76.7%	4.9%	—	4.46%
ABBV	$450B	124.8	15.6	7.2	17.2	-67.6	72.0%	12.4%	-46.2%	4.63%
PFE	$143B	19.1	8.8	2.3	7.6	1.6	74.8%	5.4%	-10.1%	8.67%
TMO	$198B	29.2	19.5	4.4	21.1	3.8	40.9%	6.2%	11.3%	2.79%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 49.23%

Holder	Shares	% out
Blackrock Inc.	19,023,590	12.57%
Capital World Investors	15,549,960	10.28%
Vanguard Portfolio Management LLC	6,823,654	4.51%
Vanguard Capital Management LLC	6,594,836	4.36%
State Street Corporation	6,429,344	4.25%
WCM Investment Management, LLC	5,923,173	3.91%
AQR Capital Management, LLC	3,981,080	2.63%
Corvex Management LP	3,829,608	2.53%
Sessa Capital IM, L.P.	3,275,849	2.17%
Geode Capital Management, LLC	3,051,279	2.02%

Insider activity · 90d

3 buys / 12 sells · ratio 0.25 · Finnhub

Meister Keith A. BUY 6,780 @ $149.19
Ullem Scott B. BUY 11,030 @ $149.19
Davies Scott M SELL 20,953 @ $180.00
Skovronsky Daniel BUY 1,674 @ $164.28
Leckman Patricia SELL 21,259 @ $167.88
Leckman Patricia SELL 21,261 @ $164.82
Leckman Patricia SELL 21,300 @ $163.36
Leckman Patricia SELL 21,378 @ $162.78
Leckman Patricia SELL 21,752 @ $161.79
Leckman Patricia SELL 22,042 @ $163.02

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low

$95.0

Mean

$167.63158

High

$220.0

Analysts

Recommendation distribution · period 2026-07-01

Revision trend (2026-04-01 → 2026-07-01): net 12 → 14 +2 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

Form	Filed	Description	Action
4	2026-07-02	PRIMARY DOCUMENT	view ·
4	2026-07-02	PRIMARY DOCUMENT	view ·
4	2026-06-25	PRIMARY DOCUMENT	view ·
4	2026-06-23	PRIMARY DOCUMENT	view ·
8-K	2026-06-23	8-K	view ·
4	2026-06-09	PRIMARY DOCUMENT	view ·
4	2026-06-04	PRIMARY DOCUMENT	view ·
4	2026-06-01	Insider transaction (Form 4)	view ·
4	2026-06-01	PRIMARY DOCUMENT	view ·
4	2026-06-01	PRIMARY DOCUMENT	view ·
8-K	2026-05-26	8-K	view ·
4	2026-05-22	PRIMARY DOCUMENT	view ·
4	2026-05-22	PRIMARY DOCUMENT	view ·
4	2026-05-22	PRIMARY DOCUMENT	view ·
4	2026-05-22	PRIMARY DOCUMENT	view ·
4	2026-05-22	PRIMARY DOCUMENT	view ·
4	2026-05-22	PRIMARY DOCUMENT	view ·
4	2026-05-22	PRIMARY DOCUMENT	view ·
4	2026-05-22	PRIMARY DOCUMENT	view ·
4	2026-05-14	Insider transaction (Form 4)	view ·
4	2026-05-11	Insider transaction (Form 4)	view ·
4	2026-05-07	PRIMARY DOCUMENT	view ·
10-Q	2026-05-04	10-Q	view ·
8-K	2026-04-30	8-K	view ·
DEF 14A	2026-04-09	DEF 14A	view ·
4	2026-04-02	PRIMARY DOCUMENT	view ·
4	2026-04-02	PRIMARY DOCUMENT	view ·
8-K	2026-04-02	8-K	view ·
4	2026-03-09	PRIMARY DOCUMENT	view ·
4	2026-03-09	PRIMARY DOCUMENT	view ·
4	2026-03-09	PRIMARY DOCUMENT	view ·
4	2026-03-09	PRIMARY DOCUMENT	view ·
4	2026-03-09	PRIMARY DOCUMENT	view ·
4	2026-03-09	PRIMARY DOCUMENT	view ·
4	2026-03-09	PRIMARY DOCUMENT	view ·
4	2026-03-09	PRIMARY DOCUMENT	view ·
4	2026-02-24	PRIMARY DOCUMENT	view ·
4	2026-02-18	PRIMARY DOCUMENT	view ·
4	2026-02-18	PRIMARY DOCUMENT	view ·
4	2026-02-18	PRIMARY DOCUMENT	view ·
4	2026-02-18	PRIMARY DOCUMENT	view ·
4	2026-02-18	PRIMARY DOCUMENT	view ·
4	2026-02-18	PRIMARY DOCUMENT	view ·
4	2026-02-18	PRIMARY DOCUMENT	view ·
4	2026-02-17	PRIMARY DOCUMENT	view ·
4	2026-02-17	PRIMARY DOCUMENT	view ·
4	2026-02-17	PRIMARY DOCUMENT	view ·
4	2026-02-17	PRIMARY DOCUMENT	view ·
4	2026-02-17	PRIMARY DOCUMENT	view ·
4	2026-02-17	PRIMARY DOCUMENT	view ·
10-K	2026-02-12	10-K	view ·
4	2026-02-11	PRIMARY DOCUMENT	view ·
8-K	2026-02-05	8-K	view ·
8-K	2026-01-30	8-K	view ·
8-K	2026-01-13	8-K	view ·
8-K	2026-01-08	8-K	view ·
4	2026-01-05	PRIMARY DOCUMENT	view ·
4	2025-12-16	PRIMARY DOCUMENT	view ·
4	2025-12-09	PRIMARY DOCUMENT	view ·
8-K	2025-11-25	8-K	view ·

About ILMN

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. The company has a collaboration with Labcorp Holdings Inc. for the development of oncology treatments through applications of sequencing solutions across the healthcare ecosystem; and strategic collaboration wit…

Options picks · ILMN

ITM + OTM ideas from the latest scan

Loading…

Congress trades · ILMN

STOCK Act disclosures

Loading…

SEC filings & insiders · ILMN

EDGAR · live

Loading…

Holders · ILMN

Institutions & insider activity

Loading…

Illumina, Inc. ILMN

Price chart

Latest bar · ILMN

Financial overlay · last 12 quarters

Compare ILMN vs peers

Earnings replay · last 20 reports

Peer comparison · Healthcare

Ownership

Top institutional holders

Insider activity · 90d

Analyst estimates

SEC filings

About ILMN

Options picks · ILMN

Congress trades · ILMN

SEC filings & insiders · ILMN

Holders · ILMN

Filing summary